BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2165088)

  • 1. Low-dose clonidine administration in the treatment of mild or moderate essential hypertension: results from a double-blind placebo-controlled study (Clobass). The Clobass Study Group.
    J Hypertens; 1990 Jun; 8(6):539-46. PubMed ID: 2165088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of low-dose antihypertensive therapy in elderly patients with predominant systolic hypertension.
    Gray DR; Weber MA; Drayer JI
    J Gerontol; 1983 May; 38(3):302-6. PubMed ID: 6841923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonidine in the elderly hypertensive. Monotherapy and therapy with a diuretic.
    Thananopavarn C; Golub MS; Sambhi MP
    Chest; 1983 Feb; 83(2 Suppl):410-1. PubMed ID: 6822140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure response to a single daily dose of a clonidine-chlorthalidone combination.
    Grossman SH; Gunnells JC
    J Clin Pharmacol; 1980 Apr; 20(4):193-6. PubMed ID: 6991550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonidine-chlorthalidone combination once and twice daily in essential hypertension.
    Noveck RJ; McMahon FG; Jain AK; Ryan JR
    Clin Pharmacol Ther; 1980 Nov; 28(5):581-6. PubMed ID: 7438676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined clonidine-chlorthalidone therapy in hypertension. Two years' experience in 30 patients.
    Rosenman RH
    Arch Intern Med; 1975 Sep; 135(9):1236-9. PubMed ID: 1164125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal administration of clonidine: a new approach to antihypertensive therapy.
    Burris JF; Mroczek WJ
    Pharmacotherapy; 1986; 6(1):30-4. PubMed ID: 3952004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of guanfacine versus clonidine for efficacy, safety and occurrence of withdrawal syndrome in step-2 treatment of mild to moderate essential hypertension.
    Wilson MF; Haring O; Lewin A; Bedsole G; Stepansky W; Fillingim J; Hall D; Roginsky M; McMahon FG; Jagger P
    Am J Cardiol; 1986 Mar; 57(9):43E-49E. PubMed ID: 3513530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in blood pressure, serum potassium and electrolytes with a combination of triamterene and a low dose of chlorthalidone.
    Hort JF; Wilkins HM
    Curr Med Res Opin; 1991; 12(7):430-40. PubMed ID: 1778085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial.
    Jo SH; Park SJ; Kim EJ; Kim SJ; Cho HJ; Song JM; Shin J; Park JJ; Shin JH; Han KR; Choi DJ
    Trials; 2018 Jun; 19(1):324. PubMed ID: 29925421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atenolol and chlorthalidone therapy for hypertension: a double-blind comparison.
    Curry RC; Schwartz KM; Urban PL
    South Med J; 1988 Nov; 81(11):1401-6, 1411. PubMed ID: 3055324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal clonidine as an adjunct to sustained-release diltiazem in the treatment of mild-to-moderate hypertension.
    Lueg MC; Herron J; Zellner S
    Clin Ther; 1991; 13(4):471-81. PubMed ID: 1933999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of isolated systolic hypertension: the SHELL study results.
    Malacco E; Mancia G; Rappelli A; Menotti A; Zuccaro MS; Coppini A;
    Blood Press; 2003; 12(3):160-7. PubMed ID: 12875478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonidine in mild to moderate hypertension: effects on blood pressure and serum lipoproteins.
    Karlberg BE; Lins LE; Rössner S
    J Hypertens Suppl; 1985 Dec; 3(4):S69-71. PubMed ID: 3913756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic treatment with tibalosine in essential hypertension.
    Staessen J; Fagard R; Fiocchi R; Lijnen P; M'Buyamba-Kabangu JR; Amery A
    Arch Int Pharmacodyn Ther; 1986 Jan; 279(1):162-76. PubMed ID: 3516092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of drug treatment in mild hypertension: VA-NHLBI feasibility trial. Plan and preliminary results of a two-year feasibility trial for a multicenter intervention study to evaluate the benefits versus the disadvantages of treating mild hypertension. Prepared for the Veterans Administration-National Heart, Lung, and Blood Institute Study Group for Evaluating Treatment in Mild Hypertension.
    Ann N Y Acad Sci; 1978 Mar; 304():267-92. PubMed ID: 360921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter double-blind comparative study of rilmenidine and clonidine in 333 hypertensive patients.
    Fillastre JP; Letac B; Galinier F; Le Bihan G; Schwartz J
    Am J Cardiol; 1988 Feb; 61(7):81D-85D. PubMed ID: 2894165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorthalidone alone or in fixed combination with slow-release metoprolol in the management of arterial hypertension: a long-term study of 545 patients.
    Bichisao E; Merlini L; Gambini O; Alberti D; Pollavini G
    J Int Med Res; 1989; 17(4):339-49. PubMed ID: 2676651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of obese hypertensive black women: a comparative study of chlorthalidone versus clonidine.
    Reisin E; Weed SG
    J Hypertens; 1992 May; 10(5):489-93. PubMed ID: 1317910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind comparison of transdermal clonidine and oral captopril in essential hypertension.
    McMahon FG; Jain AK; Vargas R; Fillingim J
    Clin Ther; 1990; 12(2):88-100. PubMed ID: 2191779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.